Drugs Made In America Acquisition II Corp.
DMII
$10.01
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -99.94% | 7,061.36% | -37.14% | ||
| Total Receivables | -- | 21,680.77% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 72.00% | 226.09% | 0.00% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -97.10% | 7,627.59% | 0.00% | ||
|
|
|||||
| Total Current Assets | -97.10% | 7,627.59% | 0.00% | ||
| Net Property, Plant & Equipment | -- | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 0.96% | 491,166.60% | 8.88% | ||
| Total Assets | 0.79% | 441,703.97% | 7.90% | ||
|
|
|||||
| Total Accounts Payable | 2,060.87% | -- | -- | ||
| Total Accrued Expenses | 1,422.41% | 163.64% | -80.53% | ||
| Short-term Debt | -- | -- | 18.87% | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -83.03% | 2,273.31% | 41.92% | ||
| Total Other Current Liabilities | -83.03% | 2,273.31% | 41.92% | ||
| Total Current Liabilities | -55.57% | 106.81% | 16.51% | ||
|
|
|||||
| Total Current Liabilities | -55.57% | 106.81% | 16.51% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | 18.87% | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 0.93% | -- | -- | ||
| Total Liabilities | 0.86% | 158,155.48% | 16.51% | ||
|
|
|||||
| Common Stock & APIC | -12.50% | -95.43% | 0.00% | ||
| Retained Earnings | -2.86% | -6,837.98% | -18.06% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -2.86% | -7,971.46% | -21.65% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -2.86% | -7,971.46% | -21.65% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -2.86% | -7,971.46% | -21.65% | ||
|
|
|||||